Wells Fargo & Company X Biotech Inc. Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in X Biotech Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 11,965 shares of XBIT stock, worth $33,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,965

Previous 11,701 2.26%

Holding current value

$33,980

Previous $46,000 17.39%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$2.99 - $4.48 $789 - $1,182	264 Added 2.26%	11,965 $38,000
Q4 2024 Feb 12, 2025	BUY	$3.8 - $8.25 $9,682 - $21,021	2,548 Added 27.84%	11,701 $46,000
Q3 2024 Nov 13, 2024	BUY	$5.55 - $7.95 $5,683 - $8,140	1,024 Added 12.6%	9,153 $70,000
Q2 2024 Aug 13, 2024	BUY	$4.54 - $9.89 $36,201 - $78,862	7,974 Added 5144.52%	8,129 $41,000
Q1 2024 May 10, 2024	BUY	$4.03 - $8.13 $12 - $24	3 Added 1.97%	155 $1,000
Q4 2023 Feb 09, 2024	BUY	$3.56 - $4.65 $28 - $37	8 Added 5.56%	152 $0
Q3 2023 Nov 13, 2023	BUY	$4.02 - $5.81 $68 - $98	17 Added 13.39%	144 $0
Q2 2023 Aug 15, 2023	BUY	$3.06 - $6.38 $15 - $31	5 Added 4.1%	127 $0
Q1 2023 May 12, 2023	BUY	$3.22 - $4.72 $6 - $9	2 Added 1.67%	122 $0
Q4 2022 Feb 13, 2023	BUY	$3.03 - $3.79 $9 - $11	3 Added 2.56%	120 $0
Q3 2022 Nov 14, 2022	BUY	$3.58 - $5.88 $53 - $88	15 Added 14.71%	117 $0
Q2 2022 Aug 12, 2022	SELL	$5.13 - $9.2 $107,796 - $193,319	-21,013 Reduced 99.52%	102 $1,000
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $139,682 - $189,315	-16,167 Reduced 43.36%	21,115 $182,000
Q4 2021 Feb 14, 2022	SELL	$10.95 - $16.07 $1.21 Million - $1.77 Million	-110,165 Reduced 74.71%	37,282 $415,000
Q3 2021 Nov 15, 2021	SELL	$12.95 - $18.24 $816,329 - $1.15 Million	-63,037 Reduced 29.95%	147,447 $1.91 Million
Q2 2021 Aug 16, 2021	SELL	$15.83 - $17.84 $269,632 - $303,868	-17,033 Reduced 7.49%	210,484 $3.49 Million
Q1 2021 May 13, 2021	BUY	$15.92 - $20.3 $1.81 Million - $2.3 Million	113,382 Added 99.34%	227,517 $3.91 Million
Q4 2020 Feb 09, 2021	BUY	$15.65 - $19.92 $654,185 - $832,675	41,801 Added 57.79%	114,135 $1.79 Million
Q3 2020 Nov 05, 2020	BUY	$13.97 - $21.16 $200,301 - $303,392	14,338 Added 24.72%	72,334 $1.38 Million
Q2 2020 Aug 13, 2020	BUY	$10.39 - $16.07 $461,991 - $714,552	44,465 Added 328.62%	57,996 $795,000
Q1 2020 May 14, 2020	BUY	$8.89 - $24.94 $120,290 - $337,463	13,531 New	13,531 $144,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.53M

Call Options Held

Put Options Held

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $86.4M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company X Biotech Inc. Transaction History